Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)† (Q27027579)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)† |
scientific article |
Statements
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)† (English)
S Gourgou-Bourgade
D Cameron
P Poortmans
B Asselain
D Azria
F Cardoso
R A'Hern
J Bogaerts
H Bonnefoi
E Brain
M J Cardoso
B Chibaudel
R Coleman
T Cufer
L Dal Lago
F Dalenc
M Debled
J Gligorov
M Gutowski
W Jacot
C Kirkove
G MacGrogan
I Negreiros
B V Offersen
F Penault Llorca
G Pruneri
H Roche
N S Russell
V Servent
B Thürlimann
M Untch
J A van der Hage
G van Tienhoven
H Wildiers
J Yarnold
F Bonnetain
S Mathoulin-Pélissier
T S Dabakuyo-Yonli
Definition for the Assessment of Time-to-event Endpoints in Cancer Trials Initiative
27 February 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference